The objective of our study was to evaluate the serum profile of IL-16, IL-18, IL-31, IL-32, IL-33, and IL-34 in patients with RA and to correlate these data with other laboratory and clinical data. The gene discussed is IL34; the disease is rheumatoid arthritis.